Daniel M. Junius

2013

In 2013, Daniel M. Junius earned a total compensation of $2.4M as President and Chief Executive Officer at ImmunoGen, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$272,250
Option Awards$1,608,890
Salary$495,000
Other$8,445
Total$2,384,585

Junius received $1.6M in option awards, accounting for 67% of the total pay in 2013.

Junius also received $272.3K in non-equity incentive plan, $495K in salary and $8.4K in other compensation.

Rankings

In 2013, Daniel M. Junius' compensation ranked 3,275th out of 12,286 executives tracked by ExecPay. In other words, Junius earned more than 73.3% of executives.

ClassificationRankingPercentile
All
3,275
out of 12,286
73rd
Division
Manufacturing
1,108
out of 4,612
76th
Major group
Chemicals And Allied Products
290
out of 1,462
80th
Industry group
Drugs
197
out of 1,156
83rd
Industry
Pharmaceutical Preparations
164
out of 890
82nd
Source: SEC filing on September 29, 2015.

Junius' colleagues

We found four more compensation records of executives who worked with Daniel M. Junius at ImmunoGen in 2013.

2013

Charles Morris

ImmunoGen

Executive Vice President and Chief Development Officer

2013

John Lambert

ImmunoGen

Executive Vice President and Distinguished Research Fellow

2013

Gregory Perry

ImmunoGen

Chief Financial Officer

2013

James O'Leary

ImmunoGen

Chief Medical Officer

In-depth

You may also like